The Role of 18F-FDG & 68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastatic
This study aims to investigate the value of 18F-FDG\&68Ga-FAPI PET/CT in evaluating the outcome of conversion therapy and the prognosis of people with peritoneal metastases from gastric cancer.
• Histologically confirmed gastric adenocarcinoma with no history of resection of primary or metastatic lesions
• Peritoneal metastases of gastric cancer requiring laparoscopy for definitive diagnosis without gastric outflow tract obstruction and intestinal obstruction
• Patients voluntarily enrolled in this study by signing an informed consent form
• Age ≥ 18 years
• Eastern Cooperative Oncology Group (ECOG) score ≤ 2,
• Expected life expectancy ≥ 3 months
• Adequate organ and bone marrow function
• Willingness to adhere to the study protocol and follow-up programme